This course will address the timely and accurate diagnosis of testicular cancer and emphasize the appropriate integration of pathologic, radiographic and serologic variables in assessing individual patient's risk in both low and high-stage germ cell tumors (GCT). Important features regarding the natural history of GCTs will also be emphasized. Patient selection and treatment options for patients with clinical stage I non-seminomatous germ cell tumors (NSGCT) such as surveillance, 1° retroperitoneal lymph node dissection (RPLND) and chemotherapy will be discussed.

Upon completion of this activity, course participants will be able to:

1. Cite current concepts and controversies in the management of low-stage and high-stage nonseminomatous germ cell tumors (NSGCTs).

2. Discuss current concepts and controversies in the management of low-stage and high-stage seminoma.

3. Describe the biology and clinical implications of teratoma.

4. Illustrate importance of tumor markers and their role in diagnosis, follow up and clinical decision making in testicular cancer.